NCT00239928 - Clinical Study Of Pegaptanib Sodium (EYE001) For Wet-Type Age-Related Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Macular Degeneration

Interventions

DRUG

pegaptanib sodium

1 drop per dosed eye per protocol.

Trial Locations (12)

Pfizer Investigational Site, Nagoya

Pfizer Investigational Site, Urayasu

Pfizer Investigational Site, Fukuoka

Pfizer Investigational Site, Fukushima

Pfizer Investigational Site, Maebashi

Pfizer Investigational Site, Sapporo

Pfizer Investigational Site, Kyoto

Pfizer Investigational Site, Moriguchi

Pfizer Investigational Site, Suita

Pfizer Investigational Site, Ōtsu

Pfizer Investigational Site, Chiyoda-ku

Pfizer Investigational Site, Shinjuku-ku